Back
Avenue Therapeutics Quote, Financials, Valuation and Earnings
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
13
ATXI
Avenue Therapeutics
Last Price:
6.06
Seasonality Move:
-7.19%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).Avenue Therapeutics Price Quote
$6.06
-0.14 (-30.94%)
(Updated: April 27, 2024 at 5:54 AM ET)
Avenue Therapeutics Key Stats
Sell
13
Avenue Therapeutics (ATXI)
is a Sell
Day range:
$5.78 - $8.99
52-week range:
$5.78 - $93.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.31%
Volume:
226.9K
Avg. volume:
28.8K
1-year change:
-90.92%
Market cap:
$3.7M
Revenue:
$0
EPS:
$-285.75
How Much Does Avenue Therapeutics Make?
Data Unavailable
Is Avenue Therapeutics Growing As A Company?
Data Unavailable
Avenue Therapeutics Stock Price Performance
-
Did Avenue Therapeutics Stock Go Up Last Month?
Avenue Therapeutics share price went down by -45.25% last month -
Did ATXI's Share Price Rise Over The Last Year?
ATXI share price fell by -90.92% over the past 1 year
What Is Avenue Therapeutics 52-Week High & Low?
-
What Is Avenue Therapeutics’s 52-Week High Share Price?
Avenue Therapeutics has traded as high as $93.75 over the past 52 weeks -
What Is Avenue Therapeutics’s 52-Week Low Share Price?
Avenue Therapeutics has traded as low as $5.78 over the past 52 weeks
Avenue Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Avenue Therapeutics?
-
How Much Debt Does Avenue Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Avenue Therapeutics Have?
Cash and short term investments quarterly total is $1.8M -
What Is Avenue Therapeutics’s Book Value Per Share?
Book value per share is 4.64
Is Avenue Therapeutics Cash Flow Positive?
-
What Is ATXI Cash Flow From Operations?
Cash flow from operations (TTM) is -$9.5M -
What Is Avenue Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $7.5M -
What Is Avenue Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Avenue Therapeutics Return On Invested Capital
Data Unavailable
Avenue Therapeutics Earnings Date & Stock Price
-
What Is Avenue Therapeutics's Stock Price Today?
A single share of ATXI can be purchased today for 6.20 -
What Is Avenue Therapeutics’s Stock Symbol?
Avenue Therapeutics trades on the nasdaq under the ticker symbol: ATXI -
When Is Avenue Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Avenue Therapeutics is scheduled on May 10, 2024 -
When Is ATXI's next ex-dividend date?
Avenue Therapeutics's next ex-dividend date is April 29, 2024 -
How To Buy Avenue Therapeutics Stock?
You can buy Avenue Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Avenue Therapeutics Competitors
-
Who Are Avenue Therapeutics's Competitors?
Below is a list of companies who compete with Avenue Therapeutics or are related in some way:
Avenue Therapeutics Dividend Yield
Data Unavailable
Avenue Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | -79.24% | 0% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 1,228.13 |
| Upside from Last Price: | 19708.52% |